CONSULTING AGREEMENTConsulting Agreement • March 7th, 2024 • Foghorn Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 7th, 2024 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made effective as of the 8th day of December, 2023(the “Effective Date”), by and between Foghorn Therapeutics Inc., a Delaware corporation with principal offices at 500 Technology Square, Suite 700, Cambridge, MA 02139 (“Company”), and Ian F. Smith, an individual residing at 104 Meadowbrook Road, Weston, MA 02493 (“Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
CONSULTING AGREEMENTConsulting Agreement • August 10th, 2021 • Foghorn Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 10th, 2021 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made effective as of the 23rd day of June, 2021 (the “Effective Date”), by and between Foghorn Therapeutics Inc., a Delaware corporation with principal offices at 500 Technology Square, Suite 700, Cambridge, MA 02139 (“Company”), and Ian F. Smith, an individual residing at 45 Commonwealth Ave, Unit 3, Boston, MA 02116 (“Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”